Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1933OMIM:612073G71.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria (also known as SUCLA2-related mitochondrial DNA depletion syndrome) is a rare inherited metabolic disorder caused by mutations in the SUCLA2 gene, which encodes the beta subunit of succinyl-CoA ligase (succinate-CoA ligase, ADP-forming). This enzyme plays a critical role in the citric acid cycle and in maintaining mitochondrial DNA (mtDNA) copy number. Deficiency leads to progressive depletion of mtDNA in affected tissues, impairing mitochondrial energy production. The condition primarily affects the brain and skeletal muscles (encephalomyopathy), and is characteristically associated with elevated methylmalonic acid in the urine (methylmalonic aciduria), which serves as a biochemical hallmark distinguishing it from other mtDNA depletion syndromes. Clinical features typically present in infancy and include hypotonia (low muscle tone), progressive muscle weakness, psychomotor delay or regression, failure to thrive, feeding difficulties, and sensorineural hearing loss. Many patients develop dystonia, seizures, and progressive encephalopathy. Lactic acidosis is commonly observed in blood and cerebrospinal fluid. Additional features may include mild hepatic involvement and growth retardation. The disease follows a progressive course, and affected individuals often experience significant neurological deterioration over time. There is currently no cure for this condition. Treatment is supportive and symptomatic, focusing on nutritional support, management of seizures with anticonvulsant medications, physical therapy, and hearing aids or cochlear implants for hearing loss. Avoidance of valproic acid is generally recommended due to its potential to worsen mitochondrial dysfunction. Supplementation with cofactors such as coenzyme Q10 and riboflavin has been tried in some patients, though evidence of efficacy remains limited. Genetic counseling is recommended for affected families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria.

View clinical trials →

No actively recruiting trials found for Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria community →

No specialists are currently listed for Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduriaForum →

No community posts yet. Be the first to share your experience with Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria.

Start the conversation →

Latest news about Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria

No recent news articles for Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria

What is Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria?

Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria (also known as SUCLA2-related mitochondrial DNA depletion syndrome) is a rare inherited metabolic disorder caused by mutations in the SUCLA2 gene, which encodes the beta subunit of succinyl-CoA ligase (succinate-CoA ligase, ADP-forming). This enzyme plays a critical role in the citric acid cycle and in maintaining mitochondrial DNA (mtDNA) copy number. Deficiency leads to progressive depletion of mtDNA in affected tissues, impairing mitochondrial energy production. The condition primarily affects the brai

How is Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria inherited?

Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria typically begin?

Typical onset of Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria is infantile. Age of onset can vary across affected individuals.